Bank of Montreal
Publication of Prospectus
Regulatory Announcement
Bank of Montreal
May 25, 2022
The following supplement has been approved by the Financial Conduct Authority and is available for viewing:
7th Supplement dated May 25 , 2022 relating to the U.S.$20,000,000,000 Note Issuance Programme of Bank of Montreal.
The 7th Supplement and the document incorporated by reference therein have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus dated July 16, 2021, as supplemented by the 1st Supplement dated August 25, 2021, the 2nd Supplement dated December 10, 2021, the 3rd Supplement dated January 4, 2022, the 4th Supplement dated January 10, 2022, the 5th Supplement dated March 1 , 2022, the 6th Supplement dated March 14, 2022 and the 7th Supplement dated May 25 , 2022 (together, the "Prospectus"), may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States and are subject to United States tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered , directly or indirectly, in the United States or to or for the account of a "U.S. person" (as defined in Regulation S under the Securities Act). No public offering of the Notes is being made in the United States. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.
Your right to access this service is conditional upon complying with the above requirement.
To view the full document, please paste the following URLs into the address bar of your browser:
7th Supplement dated May 25 , 2022
http://www.rns-pdf.londonstockexchange.com/rns/7940M_1-2022-5-25.pdf
Document Incorporated by Reference
Second Quarter 2022 Report to Shareholders
http://www.rns-pdf.londonstockexchange.com/rns/7940M_2-2022-5-25.pdf
For further information, please contact:
Sara Virani
Corporate Secretary's Dept.
Phone: 437-244-9439
Email: [email protected]
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.